Quarterly report pursuant to Section 13 or 15(d)

Marketable Securities and Fair Value Measurements

v3.22.1
Marketable Securities and Fair Value Measurements
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Marketable Securities and Fair Value Measurements

NOTE 5 —MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS

The following table sets forth the Company’s financial assets (cash equivalents and marketable securities) at fair value on a recurring basis (in thousands):

 

 

 

 

 

Basis of Fair Value Measurements

 

 

March 31, 2022

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Money market funds

$

16,913

 

 

$

16,913

 

 

$

 

 

$

 

Commercial paper

 

74,583

 

 

 

 

 

 

74,583

 

 

 

 

United States Treasury Bills

 

21,650

 

 

 

 

 

 

21,650

 

 

 

 

Government-related debt securities

 

3,003

 

 

 

 

 

 

3,003

 

 

 

 

Corporate Bonds

 

5,711

 

 

 

 

 

 

5,711

 

 

 

 

Total

$

121,860

 

 

$

16,913

 

 

$

104,947

 

 

$

 

Amounts included in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

16,913

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities, current

 

104,947

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities, non, current

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total cash equivalents and marketable securities

$

121,860

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis of Fair Value Measurements

 

 

December 31, 2021

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Money market funds

$

24,058

 

 

$

24,058

 

 

$

 

 

$

 

Commercial paper

 

103,113

 

 

 

 

 

 

103,113

 

 

 

 

United States Treasury Bills

 

14,023

 

 

 

 

 

 

14,023

 

 

 

 

Government-related debt securities

 

5,185

 

 

 

 

 

 

5,185

 

 

 

 

Corporate Bonds

 

5,726

 

 

 

 

 

 

5,726

 

 

 

 

Total

$

152,105

 

 

$

24,058

 

 

$

128,047

 

 

$

 

Amounts included in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

25,058

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities, current

 

118,061

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities, non-current

 

8,986

 

 

 

 

 

 

 

 

 

 

 

 

 

Total cash equivalents and marketable securities

$

152,105

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The Company invests in highly-liquid, investment-grade securities. The following is a summary of the Company’s available-for-sale securities (in thousands):

 

 

March 31, 2022

 

 

Cost Basis

 

 

Unrealized

Gain

 

 

Unrealized

Loss

 

 

Fair

Value

 

Cash equivalents - money market funds, commercial

   paper and corporate bonds

$

16,913

 

 

$

 

 

$

 

 

$

16,913

 

Marketable securities, current - commercial paper,

   Treasury bills and corporate bonds

 

105,246

 

 

 

 

 

 

(299

)

 

 

104,947

 

Marketable securities, non-current - Treasury bills

$

 

 

$

 

 

$

 

 

$

 

 

 

 

December 31, 2021

 

 

Cost Basis

 

 

Unrealized

Gain

 

 

Unrealized

Loss

 

 

Fair

Value

 

Cash equivalents - money market funds, commercial

   paper and corporate bonds

$

25,058

 

 

$

 

 

$

 

 

$

25,058

 

Marketable securities, current - commercial paper,

   Treasury bills and corporate bonds

$

118,084

 

 

$

6

 

 

$

(29

)

 

$

118,061

 

Marketable securities, non-current - Treasury bills

$

9,011

 

 

$

 

 

$

(25

)

 

$

8,986

 

 

The following summarized the contractual maturities of the Company’s available-for-sale investments (in thousands):

 

 

March 31, 2022

 

 

 

Cost Basis

 

 

Fair

Value

 

Due in one year or less

 

$

122,159

 

 

$

121,860

 

Due after one year through five years

 

 

 

 

 

 

Total

 

$

122,159

 

 

$

121,860

 

 

 

 

December 31, 2021

 

 

 

Cost Basis

 

 

Fair

Value

 

Due in one year or less

 

$

143,142

 

 

$

143,119

 

Due after one year through five years

 

 

9,011

 

 

 

8,986

 

Total

 

$

152,153

 

 

$

152,105

 

 

The Company received no proceeds from the sale of available-for-sale securities for the three months ended March 31, 2022 and March 31, 2021, respectively, and no realized gain for the three months ended March 31, 2022 and March 31, 2021.